NuZee EBITDA margin
Was ist das EBITDA margin von NuZee?
EBITDA margin von NuZee, Inc. ist -374.55%
Was ist die Definition von EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin von Unternehmen in Consumer Staples Sektor auf NASDAQ im Vergleich zu NuZee
Was macht NuZee?
NuZee, Inc., a specialty coffee company, engages in the manufacture, packing, and sale of single serve coffee and tea bag-style coffee for coffee roasters and suppliers in North America and South Korea. The company provides its products under Coffee Blenders, Twin Peaks, and Pine Ranch brands. It serves retail and grocery customers, office, and hospitality sectors. NuZee, Inc. was incorporated in 2011 and is headquartered in Plano, Texas.
Unternehmen mit ebitda margin ähnlich NuZee
- Surefire Resources NL hat EBITDA margin von -376.65%
- Manpasand Beverages hat EBITDA margin von -376.47%
- Legend Power Systems hat EBITDA margin von -376.36%
- Else Nutrition hat EBITDA margin von -376.29%
- Sensyne Health plc hat EBITDA margin von -375.06%
- THC Farmaceuticals hat EBITDA margin von -374.89%
- NuZee hat EBITDA margin von -374.55%
- BARD1 Life Sciences hat EBITDA margin von -373.97%
- BTCS hat EBITDA margin von -373.79%
- Abingdon Health Plc hat EBITDA margin von -373.40%
- K.B. Recycling Industries hat EBITDA margin von -372.55%
- Virtus Stone Harbor Emerging Markets Income Fund hat EBITDA margin von -372.38%
- Cazaly Resources hat EBITDA margin von -371.76%